SEC Comment Letter 0000000000-23-000961 to ANI PHARMACEUTICALS INC (ANIP) (CIK 0001023024) (ANIP)
ANI PHARMACEUTICALS INC (ANIP) (CIK 0001023024)
Date: Jan. 30, 2023 · CIK: 0001023024 · Accession: 0000000000-23-000961
AI Filing Summary & Sentiment
File numbers found in text: 001-31812
Letter
United States securities and exchange commission logo January 30, 2023 Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer ANI Pharmaceuticals, Inc. 210 Main Street West Baudette , Minnesota 56623 Re:ANI Pharmaceuticals, Inc. Form 10-K for Fiscal Year Ended December 31, 2021 Filed March 15, 2022 File No. 001-31812 Dear Stephen P. Carey: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
January 30, 2023
Stephen P. Carey
Senior Vice President, Finance and Chief Financial Officer
ANI Pharmaceuticals, Inc.
210 Main Street West
Baudette , Minnesota 56623
Re:ANI Pharmaceuticals, Inc.
Form 10-K for Fiscal Year Ended December 31, 2021
Filed March 15, 2022
File No. 001-31812
Dear Stephen P. Carey:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences